PIERIS Proteolab

PIERIS Proteolab

Develops innovative protein-based therapies with strategic partnerships to improve clinical outcomes.

Launch date
Employees
Market cap
CAD30.0m
Enterprise valuation
(CAD6m) (Public information from Sep 2024)
Company register number HRB 221043 (München)
Hallbergmoos Bavaria (HQ)
Authorizing premium user...